Kartesada

Pregabalin, the active ingredient in Kartesada, is a gabapentinoid anticonvulsant presented as an oral tablet for oral use. It is indicated for neuropathic pain, partial seizures, fibromyalgia and generalized anxiety disorder in adult patients. GNH USA supplies Kartesada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pregabalin acts on the nervous system to manage several chronic pain and seizure disorders. - Neuropathic pain: reduces pain intensity in diabetic peripheral neuropathy and post‑herpetic neuralgia. - Partial seizures (epilepsy): decreases seizure frequency in patients with focal onset seizures. - Fibromyalgia: alleviates widespread musculoskeletal pain and improves functional status. - Generalized anxiety disorder: lessens anxiety symptoms and improves overall mood.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness - Somnolence - Peripheral edema - Weight gain - Blurred vision - Dry mouth

Serious or Rare Side Effects: - Angioedema or severe swelling - Stevens‑Johnson skin reactions - Suicidal thoughts or behavior - Respiratory depression when combined with CNS depressants - Severe hypersensitivity reactions - Hematologic abnormalities such as thrombocytopenia

Pregabalin requires careful assessment and monitoring in several clinical situations. - Assess renal function: dose adjustment may be needed in patients with impaired clearance. - Monitor for mood changes: watch for signs of depression or suicidal ideation. - Evaluate for edema: patients with heart failure may be at higher risk. - Caution in elderly: increased susceptibility to dizziness and falls. - Avoid abrupt discontinuation: taper under medical supervision to reduce withdrawal risk. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture.

Pregabalin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Opioid analgesics: heightened risk of respiratory depression and profound sedation. - Benzodiazepines: additive central nervous system depression leading to excessive drowsiness. - Antihypertensives: may potentiate hypotensive effects, causing dizziness or fainting.

Moderate Interactions (Monitor Closely): - Diuretics: can increase serum pregabalin concentrations, requiring dose review. - ACE inhibitors: may raise the likelihood of angioedema. - Antacids containing aluminum or magnesium: may modestly affect absorption, monitor therapeutic response.